Cognos Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $117K
Latest Deal Amount

Cognos Therapeutics General Information

Description

Developer of diagnostic and drug delivery devices deigned to detect diseases and deliver drugs. The company's diagnostic and drug delivery devices radically advance the diagnosis and treatment of neuropathic diseases including tumor-based brain and spinal cancers, degenerative cognition disorders, cerebral trauma occurrences as well as other Central Nervous System afflictions, enabling doctors to detect diseases, monitor their patients and deliver medicines as per requirements.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Other Devices and Supplies
Primary Office
  • 10604 South La Cienega Boulevard
  • Inglewood, CA 90304
  • United States
+1 (310) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cognos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 29-May-2018 $117K 00000 Completed Startup
2. Angel (individual) 20-Apr-2016 0000 00000 Completed Startup
1. Angel (individual) 07-Dec-2015 $160K $160K Completed Startup
To view Cognos Therapeutics’s complete valuation and funding history, request access »

Cognos Therapeutics Executive Team (8)

Name Title Board Seat Contact Info
Frank Adell Chief Executive Officer & Board Member
Thomas Lobl Ph.D Chief Operating Officer
Winston Wu Chief Technology Officer & Senior Vice President of Product Development
Ian Welsford Ph.D Chief Regulatory and Compliance Office
Josh Shachar Chief Innovation Officer & Board Member
You’re viewing 5 of 8 executive team members. Get the full list »

Cognos Therapeutics Board Members (8)

Name Representing Role Since
Eli Gang Cognos Therapeutics Board Member 000 0000
Frank Adell Cognos Therapeutics Chief Executive Officer & Board Member 000 0000
Josh Shachar Cognos Therapeutics Chief Innovation Officer & Board Member 000 0000
Richard Lerner MD Cognos Therapeutics Board Member 000 0000
Roger Kornberg Ph.D Cognos Therapeutics Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »